+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Glucose Monitoring Systems Market - Global Forecast 2026-2032- Product Image
Continuous Glucose Monitoring Systems Market - Global Forecast 2026-2032- Product Image
New

Continuous Glucose Monitoring Systems Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337735
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Continuous glucose monitoring systems are redefining modern diabetes management by providing continuous, real-time health data and actionable analytics. Senior decision-makers are turning to this technology as an essential part of integrated, proactive diabetes care, recognizing its strategic alignment with evolving healthcare delivery models and the broader push toward data-driven clinical outcomes.

Market Snapshot: Continuous Glucose Monitoring Systems

The continuous glucose monitoring systems market is experiencing robust expansion, with revenue increasing from USD 4.79 billion in 2025 to USD 5.14 billion in 2026, and further projected to reach USD 7.95 billion by 2032 at a 7.50% CAGR. Growth is being driven by systematic sensor miniaturization, advanced wireless capabilities, and improved data analytics, all accelerating the rate of adoption across diverse patient groups and clinical settings. Strategic investments in R&D and evolving reimbursement models reinforce global uptake, as both established and emerging markets respond to the elevated need for reliable, real-time monitoring capabilities.

Scope & Segmentation of the Continuous Glucose Monitoring Systems Market

  • Component Types: Encompasses sensors, transmitters, and receivers, with strong focus on integrated system designs and lifecycle aftermarket offerings.
  • Device Configurations: Includes both integrated solutions where sensor and transmitter are combined, and standalone devices catering to specific clinical and patient applications.
  • Usage Duration: Covers both long-term implantable solutions for continuous use and wearable sensors for flexible, short-term monitoring needs.
  • Patient Demographics: Addresses distinct requirements of adult, pediatric, and geriatric populations, acknowledging unique physiological and usability profiles within each segment.
  • Clinical Applications: Spans the full diabetes spectrum, including type 1, type 2, and gestational diabetes, complemented by associated support and management programs.
  • Distribution Channels: Involves physical retail, direct manufacturer platforms, online e-commerce, and digital storefronts, providing choice and broadening access to end-users.
  • End Users: Ranges from ambulatory surgical centers and home care settings to hospitals, with segmentation into inpatient and outpatient pharmacy environments.
  • Geographic Coverage: Includes the Americas (North and Latin America), Europe, Middle East & Africa, and Asia-Pacific—with each region presenting specific adoption drivers and capacity-building efforts.
  • Technology Focus: Highlights minimally invasive sensor design, implementation of machine learning analytics, cloud-centric data platforms, and the maturation of closed-loop monitoring-to-delivery solutions.

Key Takeaways for Senior Decision-Makers

  • Continuous glucose monitoring systems are now an integral element in proactive care and patient engagement, enhancing disease management strategies within clinical and home environments.
  • Collaboration between medical device innovators and digital health platforms is improving device interoperability and accelerating time to market for new solutions.
  • Regulatory adaptation and the evolution of reimbursement structures continue to expand the reach of advanced monitoring technologies into underserved markets and new patient populations.
  • Personalized digital ecosystems are improving adherence, enabling remote monitoring, and supporting data-driven therapeutic pathways for diverse user groups.
  • Lifecycle support services—including device onboarding, real-time user assistance, and continuous engagement—play a pivotal role in sustaining patient retention and optimizing health outcomes.

Tariff Impact on Supply Chains and Accessibility

The implementation of US tariffs on imported medical device components in 2025 introduced considerable cost pressures for manufacturers and supply chain partners. In response, many companies accelerated domestic production and adjusted sourcing strategies to better manage expenses. Stakeholders across the distribution chain updated procurement models to accommodate increased landed costs, while industry alliances and public-private initiatives worked to strengthen local supply networks and maintain steady patient access to critical devices.

Global Adoption Dynamics

Regional uptake of continuous glucose monitoring systems is shaped by reimbursement frameworks, regulatory conditions, and healthcare infrastructure maturity. In North America, established payer systems enable expedited adoption, while in Latin America, rising diabetes prevalence spurs growing demand. Europe, the Middle East, and Africa face unique regulatory and logistical challenges, driving targeted capacity-building efforts. Asia-Pacific investment focuses on scaling remote monitoring and addressing regulatory harmonization, contributing to broader, long-term adoption across public and private healthcare sectors.

Methodology & Data Sources

This market analysis employs a rigorous, multi-stage research approach. Primary interviews with clinical authorities, device manufacturers, payers, and distribution leaders are supported by in-depth secondary research from peer-reviewed publications, regulatory submissions, and industry white papers. Triangulation and iterative review confirm data reliability and ensure findings support actionable strategy.

Why This Report Matters

  • Empowers senior leaders, investors, and healthcare providers to make informed decisions in an evolving diabetes care landscape through structured market intelligence.
  • Identifies actionable segmentation and emerging technology trends that support customized go-to-market strategies and drive product innovation.
  • Serves as a benchmark for regulatory and payer engagement, helping organizations position themselves effectively within the dynamic diabetes device segment.

Conclusion

Continuous glucose monitoring systems are transforming the approaches used to manage diabetes and streamline healthcare delivery. Strategic engagement with real-time data, evolving technologies, and collaborative supply chain initiatives offers sustainable value as markets progress.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Continuous Glucose Monitoring Systems Market, by Component
8.1. Receivers/Monitors
8.2. Sensors
8.3. Transmitters
9. Continuous Glucose Monitoring Systems Market, by Type of Device
9.1. Integrated CGM Systems
9.2. Standalone CGM Systems
10. Continuous Glucose Monitoring Systems Market, by Duration of Use
10.1. Long-Term Implantable CGMs
10.2. Short-Term Wearable CGMs
11. Continuous Glucose Monitoring Systems Market, by Patient Age Group
11.1. Adults
11.2. Children
11.3. Geriatric
12. Continuous Glucose Monitoring Systems Market, by Application
12.1. Gestational Diabetes
12.2. Type 1 Diabetes
12.3. Type 2 Diabetes
13. Continuous Glucose Monitoring Systems Market, by Distribution Channel
13.1. Offline
13.2. Online
13.2.1. eCommerce Platforms
13.2.2. Manufacturer Websites
14. Continuous Glucose Monitoring Systems Market, by End User
14.1. Ambulatory Surgical Centers
14.2. Home Care Settings
14.3. Hospitals & Clinics
14.3.1. Inpatient Pharmacies
14.3.2. Outpatient Pharmacies
15. Continuous Glucose Monitoring Systems Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Continuous Glucose Monitoring Systems Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Continuous Glucose Monitoring Systems Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Continuous Glucose Monitoring Systems Market
19. China Continuous Glucose Monitoring Systems Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. A. Menarini Diagnostics s.r.l
20.6. Abbott Laboratories
20.7. AgaMatrix Inc. by I-Sens Inc.
20.8. Ascensia Diabetes Care Holdings AG
20.9. Dexcom, Inc.
20.10. F. Hoffmann-La Roche Ltd.
20.11. Insulet Corporation
20.12. Johnson & Johnson Services, Inc.
20.13. Medtronic PLC
20.14. Medtrum Technologies Inc.
20.15. Nemaura Medical Inc.
20.16. Novo Nordisk A/S
20.17. NXP Semiconductors N.V.
20.18. Senseonics Holdings Inc.
20.19. Sibionics
20.20. Signos, Inc.
20.21. STMicroelectronics N.V.
20.22. Tandem Diabetes Care, Inc.
20.23. Texas Instruments Incorporated
20.24. Ypsomed Holding AG
List of Figures
FIGURE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS/MONITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS/MONITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS/MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED CGM SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED CGM SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED CGM SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STANDALONE CGM SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STANDALONE CGM SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STANDALONE CGM SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LONG-TERM IMPLANTABLE CGMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LONG-TERM IMPLANTABLE CGMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LONG-TERM IMPLANTABLE CGMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SHORT-TERM WEARABLE CGMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SHORT-TERM WEARABLE CGMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SHORT-TERM WEARABLE CGMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ECOMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ECOMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INPATIENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INPATIENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OUTPATIENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OUTPATIENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 118. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 120. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 121. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 122. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 123. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 126. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 138. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 140. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 141. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 142. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 143. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 146. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 161. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 162. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 163. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 164. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 167. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 169. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 171. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 172. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 173. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 174. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 177. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 189. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 191. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 192. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 193. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 194. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 197. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 199. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 201. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 202. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 203. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 204. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 207. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 209. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 211. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 212. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 213. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 214. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 217. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 230. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 231. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 232. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2032 (USD MILLION)
TABLE 233. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2032 (USD MILLION)
TABLE 234. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 235. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 238. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Continuous Glucose Monitoring Systems market report include:
  • A. Menarini Diagnostics s.r.l
  • Abbott Laboratories
  • AgaMatrix Inc. by I-Sens Inc.
  • Ascensia Diabetes Care Holdings AG
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Novo Nordisk A/S
  • NXP Semiconductors N.V.
  • Senseonics Holdings Inc.
  • Sibionics
  • Signos, Inc.
  • STMicroelectronics N.V.
  • Tandem Diabetes Care, Inc.
  • Texas Instruments Incorporated
  • Ypsomed Holding AG

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.14 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.95 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Continuous Blood Glucose Monitoring Systems Market - Global Forecast 2026-2032 - Product Image

Continuous Blood Glucose Monitoring Systems Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Continuous Glucose Monitoring Device Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Continuous Glucose Monitoring Device Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Continuous Glucose Monitoring System Market by Product Type, Technology, Application, Age Group, Distribution Channel, End-user - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Continuous Glucose Monitoring System Market by Product Type, Technology, Application, Age Group, Distribution Channel, End-user - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 205 Pages
  • Global
From
Continuous Glucose Monitoring Devices Market Report 2025 - Product Image

Continuous Glucose Monitoring Devices Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Continuous Glucose Monitoring Devices Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Continuous Glucose Monitoring Devices Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 97 Pages
  • Global
From

About the Continuous Glucose Monitoring Market

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low. Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.